Logo Logo

Publications by Vlotides, George

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 3.

Journal article

Reuther, Clemens; Heinzle, Vera; Spampatti, Matilde; Vlotides, George; De Toni, Enrico; Spöttl, Gerald; Maurer, Julian; Nölting, Svenja; Göke, Burkhard; Auernhammer, Christoph J. (2016): Cabozantinib and Tivantinib, but Not INC280, Induce Antiproliferative and Antimigratory Effects in Human Neuroendocrine Tumor Cells in vitro: Evidence for 'Off-Target' Effects Not Mediated by c-Met Inhibition. In: Neuroendocrinology, Vol. 103, No. 3-4: pp. 383-401 [PDF, 916kB]

Nölting, Svenja; Giubellino, Alessio; Tayem, Yasin; Young, Karen; Lauseker, Michael; Bullova, Petra; Schovanek, Jan; Anver, Miriam; Fliedner, Stephanie; Korbonits, Marta; Göke, Burkhard; Vlotides, George; Grossman, Ashley; Pacak, Karel (July 2014): Combination of 13-Cis Retinoic Acid and Lovastatin: Marked Antitumor Potential In Vivo in a Pheochromocytoma Allograft Model in Female Athymic Nude Mice. In: Endocrinology, Vol. 155, No. 7: pp. 2377-2390

Zitzmann, Kathrin; Andersen, Sandra; Vlotides, George; Spoettl, Gerald; Zhang, Shengwen; Datta, Rakesh; Culler, Michael; Göke, Burkhard; Auernhammer, Christoph J. (2013): The Novel Somatostatin Receptor 2/Dopamine Type 2 Receptor Chimeric Compound BIM-23A758 Decreases the Viability of Human GOT1 Midgut Carcinoid Cells. In: Neuroendocrinology, No. 2: pp. 128-136 [PDF, 782kB]

This list was generated on Mon Aug 8 19:20:56 2022 CEST.